HK1054391A1 - 毒蕈碱拮抗劑 - Google Patents
毒蕈碱拮抗劑Info
- Publication number
- HK1054391A1 HK1054391A1 HK03106691.6A HK03106691A HK1054391A1 HK 1054391 A1 HK1054391 A1 HK 1054391A1 HK 03106691 A HK03106691 A HK 03106691A HK 1054391 A1 HK1054391 A1 HK 1054391A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- muscarinic antagonists
- muscarinic
- antagonists
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
- 239000003149 muscarinic antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25785300P | 2000-12-22 | 2000-12-22 | |
| PCT/US2001/049063 WO2002051808A2 (en) | 2000-12-22 | 2001-12-17 | Muscarinic antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1054391A1 true HK1054391A1 (zh) | 2003-11-28 |
Family
ID=22978046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK03106691.6A HK1054391A1 (zh) | 2000-12-22 | 2003-09-18 | 毒蕈碱拮抗劑 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6458812B1 (zh) |
| EP (1) | EP1343760B1 (zh) |
| JP (2) | JP4012068B2 (zh) |
| CN (1) | CN1481360A (zh) |
| AR (1) | AR035612A1 (zh) |
| AT (1) | ATE439344T1 (zh) |
| AU (1) | AU2002235224A1 (zh) |
| CA (1) | CA2431952C (zh) |
| DE (1) | DE60139571D1 (zh) |
| ES (1) | ES2329975T3 (zh) |
| HK (1) | HK1054391A1 (zh) |
| MX (1) | MXPA03005743A (zh) |
| MY (1) | MY133992A (zh) |
| PE (1) | PE20020657A1 (zh) |
| WO (1) | WO2002051808A2 (zh) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7700603B2 (en) * | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| AU2005289808B2 (en) * | 2004-09-24 | 2011-11-03 | The Government Of The United States As Represented By The Secretary Of The Army, U.S. Army Medical Research Institute Of Chemical Defense | Method of treating organophosphorous poisoning |
| US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
| US7678116B2 (en) | 2004-12-06 | 2010-03-16 | Dfine, Inc. | Bone treatment systems and methods |
| US7559932B2 (en) * | 2004-12-06 | 2009-07-14 | Dfine, Inc. | Bone treatment systems and methods |
| US7722620B2 (en) | 2004-12-06 | 2010-05-25 | Dfine, Inc. | Bone treatment systems and methods |
| CN101198595A (zh) * | 2005-06-14 | 2008-06-11 | 先灵公司 | 天冬氨酰基蛋白酶抑制剂 |
| US7812013B2 (en) * | 2005-06-14 | 2010-10-12 | Schering Corporation | Macrocyclic heterocyclic aspartyl protease inhibitors |
| BRPI0612545A2 (pt) | 2005-06-14 | 2010-11-23 | Schering Corp | compostos inibidores de protease, composições farmacêuticas e uso dos mesmos |
| KR20080029965A (ko) | 2005-06-14 | 2008-04-03 | 쉐링 코포레이션 | 아스파르틸 프로테아제 억제제 |
| DE602006018456D1 (de) | 2005-06-14 | 2011-01-05 | Schering Corp | Herstellung und verwendung von verbindungen als aspartylproteasehemmer |
| US20080027456A1 (en) * | 2006-07-19 | 2008-01-31 | Csaba Truckai | Bone treatment systems and methods |
| US8696679B2 (en) | 2006-12-08 | 2014-04-15 | Dfine, Inc. | Bone treatment systems and methods |
| WO2008073370A1 (en) * | 2006-12-12 | 2008-06-19 | Schering Corporation | Aspartyl protease inhibitors containing a tricyclic ring system |
| MX2009006228A (es) | 2006-12-12 | 2009-06-22 | Schering Corp | Inhibidores de aspartil proteasa. |
| WO2008137428A2 (en) | 2007-04-30 | 2008-11-13 | Dfine, Inc. | Bone treatment systems and methods |
| WO2009032277A1 (en) | 2007-09-06 | 2009-03-12 | Schering Corporation | Gamma secretase modulators |
| US8487099B2 (en) | 2007-11-05 | 2013-07-16 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
| MX2010006378A (es) * | 2007-12-11 | 2010-09-07 | Schering Corp | Moduladores de gamma secretasa. |
| CA2742486A1 (en) | 2008-11-13 | 2010-05-20 | Schering Corporation | Gamma secretase modulators |
| TW201034666A (en) | 2008-12-22 | 2010-10-01 | Schering Corp | Gamma secretase modulators |
| CA2747750A1 (en) | 2008-12-22 | 2010-07-01 | Theodros Asberom | Gamma secretase modulators |
| US20120010264A1 (en) * | 2009-03-26 | 2012-01-12 | Dainippon Sumitomo Pharma Co., Ltd. | Novel medicament for treating cognitive impairment |
| US20120245158A1 (en) | 2009-06-16 | 2012-09-27 | Xianhai Huang | Gamma secretase modulators |
| EP2443118A1 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | Gamma secretase modulators |
| EP2443121A2 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | Gamma secretase modulators |
| US20110281853A1 (en) | 2010-05-12 | 2011-11-17 | Rishi Arora | Compositions and methods for treating or preventing atrial fibrillation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04312572A (ja) * | 1991-04-12 | 1992-11-04 | Takeda Chem Ind Ltd | 環状アミン化合物 |
| IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| TW542822B (en) * | 1997-01-17 | 2003-07-21 | Ajinomoto Kk | Benzamidine derivatives |
| US6066636A (en) * | 1998-06-30 | 2000-05-23 | Schering Corporation | Muscarinic antagonists |
-
2001
- 2001-12-17 CA CA002431952A patent/CA2431952C/en not_active Expired - Fee Related
- 2001-12-17 MX MXPA03005743A patent/MXPA03005743A/es active IP Right Grant
- 2001-12-17 DE DE60139571T patent/DE60139571D1/de not_active Expired - Lifetime
- 2001-12-17 EP EP01985584A patent/EP1343760B1/en not_active Expired - Lifetime
- 2001-12-17 WO PCT/US2001/049063 patent/WO2002051808A2/en active Application Filing
- 2001-12-17 JP JP2002552905A patent/JP4012068B2/ja not_active Expired - Fee Related
- 2001-12-17 CN CNA018209718A patent/CN1481360A/zh active Pending
- 2001-12-17 US US10/023,277 patent/US6458812B1/en not_active Expired - Fee Related
- 2001-12-17 AT AT01985584T patent/ATE439344T1/de not_active IP Right Cessation
- 2001-12-17 ES ES01985584T patent/ES2329975T3/es not_active Expired - Lifetime
- 2001-12-17 AR ARP010105838A patent/AR035612A1/es unknown
- 2001-12-17 AU AU2002235224A patent/AU2002235224A1/en not_active Abandoned
- 2001-12-18 PE PE2001001266A patent/PE20020657A1/es not_active Application Discontinuation
- 2001-12-19 MY MYPI20015743A patent/MY133992A/en unknown
-
2003
- 2003-09-18 HK HK03106691.6A patent/HK1054391A1/zh unknown
-
2007
- 2007-08-03 JP JP2007203608A patent/JP2007297410A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2431952A1 (en) | 2002-07-04 |
| CN1481360A (zh) | 2004-03-10 |
| US6458812B1 (en) | 2002-10-01 |
| ES2329975T3 (es) | 2009-12-03 |
| JP2004516313A (ja) | 2004-06-03 |
| EP1343760B1 (en) | 2009-08-12 |
| MY133992A (en) | 2007-11-30 |
| EP1343760A2 (en) | 2003-09-17 |
| JP2007297410A (ja) | 2007-11-15 |
| MXPA03005743A (es) | 2003-09-05 |
| CA2431952C (en) | 2010-03-09 |
| PE20020657A1 (es) | 2002-07-23 |
| WO2002051808A3 (en) | 2003-01-23 |
| AR035612A1 (es) | 2004-06-16 |
| DE60139571D1 (de) | 2009-09-24 |
| ATE439344T1 (de) | 2009-08-15 |
| JP4012068B2 (ja) | 2007-11-21 |
| AU2002235224A1 (en) | 2002-07-08 |
| WO2002051808A2 (en) | 2002-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1054391A1 (zh) | 毒蕈碱拮抗劑 | |
| HK1058196A1 (en) | Muscarinic agonists | |
| IL156304A0 (en) | Cxcr3 antagonists | |
| DZ3293A1 (fr) | Arylpyrazines substitues | |
| AU6227101A (en) | Substituted iminoazines | |
| HUP0303043A3 (en) | Rhinological agents | |
| AU6031001A (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
| IL140249A0 (en) | Muscarinic antagonists | |
| IL152701A0 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
| AU5825501A (en) | Substituted benzoylcyclohexenones | |
| PL358119A1 (en) | Substituted phenyluracils | |
| HK1043590A1 (zh) | 毒蕈碱性拮抗物 | |
| GB0012082D0 (en) | Phamaceutical compositions | |
| HK1054326A1 (en) | Endoparasiticidal agents | |
| GB0021040D0 (en) | Drills | |
| GB0109060D0 (en) | Multi-purpose attachment device | |
| AU2360402A (en) | Substituted phenyluracils | |
| LU90708B1 (en) | Lihtweight construction | |
| GB0009125D0 (en) | Antagonists | |
| GB0006860D0 (en) | Antagonists | |
| GB0003963D0 (en) | Muscarinic agents | |
| GB2369445B (en) | Component measures | |
| GB0103519D0 (en) | Muscarinic agents | |
| AU1893P (en) | Novasnow Sutera cordata | |
| CA89636S (en) | Upright tool case |